Genprex
GNPX
21 hedge funds and large institutions have $1.16M invested in Genprex in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
24% more funds holding
Funds holding: 17 → 21 (+4)
0% less ownership
Funds ownership: 0% → 0% (-0%)
56% less capital invested
Capital invested by funds: $2.61M → $1.16M (-$1.45M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$92.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$46.1K |
| 3 |
Squarepoint
New York
|
+$34.6K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$23.1K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$358K |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
-$321K |
| 3 |
CC
Cypress Capital
Franklin,
Tennessee
|
-$39.5K |
| 4 |
VF
Virtu Financial
New York
|
-$24K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$11.7K |
GNPX Hedge Fund Activity: Q4 2023 in Review
21 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2023, worth a combined $1.16M — down 56% from $2.61M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GNPX positions and 4 closed out — a net gain of 4 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $92.3K. The largest seller was CVI Holdings, cutting an estimated $358K.
- 21 institutional investors held Genprex (GNPX) as of Q4 2023, up from 17 in Q3 2023.
- Funds reported $1.16M of Genprex stock for Q4 2023, down 56% quarter-over-quarter.
- 8 funds opened new Genprex positions in Q4 2023 and 4 closed out, a net change of +4 holders.
- The largest Genprex buyer in Q4 2023 was Renaissance Technologies, an estimated $92.3K added.
- The largest Genprex seller in Q4 2023 was CVI Holdings, an estimated $358K sold.
Based on aggregated 13F filings for Q4 2023.